Evidence map›Paper›PMID 26511606›Full record

ArticleRetrovirology2015

Fluorescent protein-tagged Vpr dissociates from HIV-1 core after viral fusion and rapidly enters the cell nucleus.

Tanay M Desai, Mariana Marin, Chetan Sood, Jiong Shi, Fatima Nawaz, Christopher Aiken, Gregory B Melikyan

Open access · goldAbstract read
In one paragraph

Article in Retrovirology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
2.7field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 49 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Tanay M DesaiDivision of Pediatric Infectious Diseases, Emory University School of Medicine, Atlanta, GA, USA. tanay.desai@emory.edu.
Mariana MarinDivision of Pediatric Infectious Diseases, Emory University School of Medicine, Atlanta, GA, USA. mariana.marin@emory.edu.
Chetan SoodDivision of Pediatric Infectious Diseases, Emory University School of Medicine, Atlanta, GA, USA. chetan.sood@emory.edu.
Jiong ShiDepartment of Pathology, Microbiology and Immunology, Vanderbilt University, Nashville, TN, 37232, USA. jiong.shi@Vanderbilt.Edu.
Fatima NawazDepartment of Pathology, Microbiology and Immunology, Vanderbilt University, Nashville, TN, 37232, USA. fatima.nawaz@vanderbilt.edu.
Christopher AikenDepartment of Pathology, Microbiology and Immunology, Vanderbilt University, Nashville, TN, 37232, USA. chris.aiken@Vanderbilt.edu.
Gregory B MelikyanDivision of Pediatric Infectious Diseases, Emory University School of Medicine, Atlanta, GA, USA. gmeliki@emory.edu.
Emory University · USVanderbilt University · USChildren's Healthcare of Atlanta · US

Funding

X-Ray Core P50GM082251 · NIGMS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI ENGELMAN, ALAN N. · 2007 to 2018
$48.1M
BIOPHYSICS OF PROTEIN-MEDIATED MEMBRANE FUSIONR01GM054787 · NIGMS · UNIVERSITY OF MD BIOTECHNOLOGY INSTITUTE · PI MELIKIAN, GREGORY B · 2000 to 2018
$6.5M
BIOPHYSICS OF PROTEIN MEDIATED MEMBRANE FUSIONR29GM054787 · NIGMS · RUSH UNIVERSITY MEDICAL CENTER · PI MELIKIAN, GREGORY B · 1996 to 1999
–
NIGMS NIH HHS P50 GM082251NIGMS NIH HHS P50GM082251NIGMS NIH HHS R01 GM054787NIGMS NIH HHS R01GM054787NIGMS NIH HHS R29 GM054787
6 · The paper itself

Abstract

backgroundHIV-1 Vpr is recruited into virions during assembly and appears to remain associated with the viral core after the reverse transcription and uncoating steps of entry. This feature has prompted the use of fluorescently labeled Vpr to visualize viral particles and to follow trafficking of post-fusion HIV-1 cores in the cytoplasm.

resultsHere, we tracked single pseudovirus entry and fusion and observed that fluorescently tagged Vpr gradually dissociates from post-fusion viral cores over the course of several minutes and accumulates in the nucleus. Kinetics measurements showed that fluorescent Vpr released from the cores very rapidly entered the cell nucleus. More than 10,000 Vpr molecules can be delivered into the cell nucleus within 45 min of infection by HIV-1 particles pseudotyped with the avian sarcoma and leukosis virus envelope glycoprotein. The fraction of Vpr from cell-bound viruses that accumulated in the nucleus was proportional to the extent of virus-cell fusion and was fully blocked by viral fusion inhibitors. Entry of virus-derived Vpr into the nucleus occurred independently of envelope glycoproteins or target cells. Fluorescence correlation spectroscopy revealed two forms of nuclear Vpr-monomers and very large complexes, likely involving host factors. The kinetics of viral Vpr entering the nucleus after fusion was not affected by point mutations in the capsid protein that alter the stability of the viral core.

conclusionsThe independence of Vpr shedding of capsid stability and its relatively rapid dissociation from post-fusion cores suggest that this process may precede capsid uncoating, which appears to occur on a slower time scale. Our results thus demonstrate that a bulk of fluorescently labeled Vpr incorporated into HIV-1 particles is released shortly after fusion. Future studies will address the question whether the quick and efficient nuclear delivery of Vpr derived from incoming viruses can regulate subsequent steps of HIV-1 infection.

Indexed as

Active Transport, Cell NucleusCapsid ProteinsCell NucleusCytoplasmFluorescence Recovery After PhotobleachingHeLa CellsHIV-1HumansSpectrometry, FluorescenceVirionVirus InternalizationVirus Replicationvpr Gene Products, Human Immunodeficiency VirusCapsid Proteinsvpr Gene Products, Human Immunodeficiency Virus

Identifiers

PMID26511606
PMCPMC4625717
OpenAlexW2099684223

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.